GTx Up Nearly 26% (GTXI)

Shares of GTx, Inc. GTXI are soaring this morning after the tiny biotech company was upgraded at Citigroup. At last check, shares of GTx, Inc. were up 73 cents to $3.48, a gain of 26.5%. GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules to treat cancer, osteoporosis and bone loss, muscle loss, and other serious medical conditions.